Zoetis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

73.00$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Zoetis Inc (ZTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,468 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZTS
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	2,151	2,213	2,190	2,361	2,388	2,317	2,220	2,460	2,400	2,387	2,262	2,468	9,517
Cost of Revenue	676	765	680	703	736	741	654	682	715	743	641	673	2,772
Gross Profit	1,475	1,448	1,510	1,658	1,652	1,576	1,566	1,778	1,685	1,644	1,621	1,795	6,745
Research & Development	152	174	162	171	167	186	157	172	170	199	180	173	722
Selling, General & Administrative	525	284	547	581	565	625	563	617	579	619	588	592	2,378
Total Operating Expenses	677	739	709	752	732	811	720	789	749	818	799	858	3,224
Operating Income	798	709	801	906	920	765	846	989	936	826	822	937	3,521
Interest Expense	63	59	62	63	61	56	59	58	64	57	62	61	244
Pre-Tax Income	717	650	747	780	874	732	810	902	887	761	758	866	3,272
Income Tax Expense	121	127	148	156	182	151	179	184	166	158	157	175	656
Net Income	596	525	599	624	682	581	631	718	721	603	601	691	2,616
EBITDA	904	835	935	970	1,056	911	988	1,083	1,069	939	939	927	3,874

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings